Doctors warn US response to monkeypox is lagging behind

The Centers for Disease Control and Prevention has identified more than 1,000 cases of monkeypox in the United States, but even though the federal government has plenty of treatments and vaccines, doctors say bureaucracy is hampering their ability to respond and contain the virus. epidemic. .

It’s “almost impossible” for doctors and clinics to offer patients the antiviral monkeypox TPOXX, even if New York City has an adequate supply, said Mary Foote, medical director of compounding and emergency response at the New York City Department of Health and Health. Mental hygiene.

She warned that the true number of monkeypox cases in the United States is likely well over 1,000 because many people cannot easily access testing.

“If we’ve learned anything from the COVID-19 pandemic, it’s that we need to pay attention to these kinds of things so they don’t get worse,” said Lilian Abbo, deputy chief medical officer for diseases. infections for Jackson’s health system in Miami. Abbo and Foote spoke to reporters on Thursday about treatment issues during a call hosted by the Infectious Diseases Society of America.

The treatment for monkeypox, TPOXX, is only available to patients and physicians under special CDC status because it is typically used to treat smallpox, not monkeypox.

Comments are closed.